Literature DB >> 22136167

Regulation of immune responses by mTOR.

Jonathan D Powell1, Kristen N Pollizzi, Emily B Heikamp, Maureen R Horton.   

Abstract

mTOR is an evolutionarily conserved serine/threonine kinase that plays a central role in integrating environmental cues in the form of growth factors, amino acids, and energy. In the study of the immune system, mTOR is emerging as a critical regulator of immune function because of its role in sensing and integrating cues from the immune microenvironment. With the greater appreciation of cellular metabolism as an important regulator of immune cell function, mTOR is proving to be a vital link between immune function and metabolism. In this review, we discuss the ability of mTOR to direct the adaptive immune response. Specifically, we focus on the role of mTOR in promoting differentiation, activation, and function in T cells, B cells, and antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136167      PMCID: PMC3616892          DOI: 10.1146/annurev-immunol-020711-075024

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  171 in total

Review 1.  Th17: an effector CD4 T cell lineage with regulatory T cell ties.

Authors:  Casey T Weaver; Laurie E Harrington; Paul R Mangan; Maya Gavrieli; Kenneth M Murphy
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

Review 2.  Innate immune recognition of viral infection.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2006-02       Impact factor: 25.606

Review 3.  mTOR and cancer: insights into a complex relationship.

Authors:  David M Sabatini
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

4.  Sequence motifs in IL-4R alpha mediating cell-cycle progression of primary lymphocytes.

Authors:  Linda M Stephenson; Do-Sim Park; Ana L Mora; Shreevrat Goenka; Mark Boothby
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

5.  Kruppel-like factor 2 regulates thymocyte and T-cell migration.

Authors:  Corey M Carlson; Bart T Endrizzi; Jinghai Wu; Xiaojie Ding; Michael A Weinreich; Elizabeth R Walsh; Maqsood A Wani; Jerry B Lingrel; Kristin A Hogquist; Stephen C Jameson
Journal:  Nature       Date:  2006-07-20       Impact factor: 49.962

6.  TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

Authors:  Ken Inoki; Hongjiao Ouyang; Tianqing Zhu; Charlotta Lindvall; Yian Wang; Xiaojie Zhang; Qian Yang; Christina Bennett; Yuko Harada; Kryn Stankunas; Cun-Yu Wang; Xi He; Ormond A MacDougald; Ming You; Bart O Williams; Kun-Liang Guan
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

7.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

Review 8.  AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.

Authors:  Hiroyuki Motoshima; Barry J Goldstein; Motoyuki Igata; Eiichi Araki
Journal:  J Physiol       Date:  2006-04-13       Impact factor: 5.182

9.  Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.

Authors:  Sara Colombetti; Veronica Basso; Daniel L Mueller; Anna Mondino
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

10.  Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes.

Authors:  Peter Tamás; Simon A Hawley; Rosemary G Clarke; Kirsty J Mustard; Kevin Green; D Grahame Hardie; Doreen A Cantrell
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  337 in total

1.  Fueling memories.

Authors:  Jonathan D Powell; Kristen Pollizzi
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

2.  Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase.

Authors:  Jonatan Ersching; Alejo Efeyan; Luka Mesin; Johanne T Jacobsen; Giulia Pasqual; Brian C Grabiner; David Dominguez-Sola; David M Sabatini; Gabriel D Victora
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 3.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

4.  Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.

Authors:  Yanyan Wang; Gonghua Huang; Hu Zeng; Kai Yang; Richard F Lamb; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

Review 5.  Metabolism of inflammation limited by AMPK and pseudo-starvation.

Authors:  Luke A J O'Neill; D Grahame Hardie
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

6.  Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

Authors:  Hung D Nguyen; Shilpak Chatterjee; Kelley M K Haarberg; Yongxia Wu; David Bastian; Jessica Heinrichs; Jianing Fu; Anusara Daenthanasanmak; Steven Schutt; Sharad Shrestha; Chen Liu; Honglin Wang; Hongbo Chi; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

7.  Suppression by TFR cells leads to durable and selective inhibition of B cell effector function.

Authors:  Peter T Sage; Noga Ron-Harel; Vikram R Juneja; Debattama R Sen; Seth Maleri; Waradon Sungnak; Vijay K Kuchroo; W Nicholas Haining; Nicolas Chevrier; Marcia Haigis; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2016-10-03       Impact factor: 25.606

8.  Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism.

Authors:  Terri N Iwata; Julita A Ramírez; Mark Tsang; Heon Park; Daciana H Margineantu; David M Hockenbery; Brian M Iritani
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

Review 9.  Moving towards personalized treatments of immune-related adverse events.

Authors:  Khashayar Esfahani; Arielle Elkrief; Cassandra Calabrese; Réjean Lapointe; Marie Hudson; Bertrand Routy; Wilson H Miller; Leonard Calabrese
Journal:  Nat Rev Clin Oncol       Date:  2020-04-03       Impact factor: 66.675

Review 10.  Role of diacylglycerol kinases in T cell development and function.

Authors:  Sruti Krishna; Xiaoping Zhong
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.